{"id":"clm_F100EC2AA0AB","entity":"gilead-sciences","predicate":"total_equity","value":"7,313,612,000 United States dollar","value_json":{"fp":"Q1","fy":2012,"accn":"0001445305-12-001487","form":"10-Q","filed":"2012-05-04","period":"Q1 FY2012","concept":"us-gaap:StockholdersEquity"},"valid_from":"2012-03-31","valid_to":"2012-06-30","published":"2012-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Gilead Sciences total equity: 7,313,612,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_F100EC2AA0AB, https://asof.is/claim/clm_F100EC2AA0AB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000144530512001487/0001445305-12-001487-index.htm.","url":"https://asof.is/claim/clm_F100EC2AA0AB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_67DBD97EDB58","supersedes":["clm_019E95D10520"],"first_seen_at":"2026-11-08T15:39:34.353214+00:00","updated_at":"2026-11-08T15:39:41.883733+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/882095/000144530512001487/0001445305-12-001487-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2012","published_at":"2012-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-05-04"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}